VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $290,000 | -99.8% | 2,850 | -99.6% | 0.03% | -99.5% |
| Q3 2015 | $132,039,000 | -19.5% | 740,209 | +0.2% | 5.98% | +4.5% |
| Q2 2015 | $164,088,000 | -7.5% | 738,636 | -17.3% | 5.72% | +0.9% |
| Q1 2015 | $177,339,000 | +34.3% | 892,860 | -3.3% | 5.67% | +31.0% |
| Q4 2014 | $132,077,000 | +5.0% | 922,910 | -3.7% | 4.33% | +12.1% |
| Q3 2014 | $125,728,000 | +3.3% | 958,293 | -0.7% | 3.86% | +10.9% |
| Q2 2014 | $121,653,000 | -4.9% | 964,583 | -0.6% | 3.48% | -11.1% |
| Q1 2014 | $127,900,000 | -24.0% | 970,193 | -32.3% | 3.92% | -24.8% |
| Q4 2013 | $168,335,000 | +10.8% | 1,433,854 | -0.3% | 5.21% | +6.2% |
| Q3 2013 | $151,989,000 | +20.6% | 1,437,663 | -1.8% | 4.90% | +4.2% |
| Q2 2013 | $126,000,000 | – | 1,463,749 | – | 4.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |